Henry Schein partnered with Cerebral Assessment Systems to distribute Cognivue, a computerized assessment screening device to detect early signs of dementia.
Here are five things to know:
1. Cognivue is designed to help physicians monitor current brain health and identify future reversible dementia treatment options.
2. The device displays controlled visual stimuli on a computer screen, allowing physicians to conduct quantitative analysis of brain health.
3. Cognivue then summarizes the results into a single quantitative brain health score, enabling physicians to identify potential issues.
4. Cognivue monitors and measures how the brain processes information. The test is customized based on the individual patient, calibrating levels of difficulty based on how well a patient's brain is performing.
5. Charles Duffy, MD, created Cognivue based on years of neurophysiological and psychophysical research.